Lensar (LNSR) EPS (Basic) Growth (1y) (2020 - 2026)
Lensar (LNSR) EPS (Basic) Growth (1y) (2020 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Basic) Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 154.42 Bn | 147.76 Bn | 6.27 Bn | -18.42% |
| 2 | Stryker | 118.12 Bn | 115.25 Bn | 3.81 Bn | 14.04% |
| 3 | Medtronic | 101.72 Bn | 93.55 Bn | 5.76 Bn | -11.88% |
| 4 | Boston Scientific | 67.19 Bn | 65.98 Bn | 3.61 Bn | 95.65% |
| 5 | Edwards Lifesciences | 50.69 Bn | 47.02 Bn | 1.29 Bn | 8.20% |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | - |
| 7 | Dexcom | 28.09 Bn | 26.97 Bn | 750.30 Mn | 92.59% |
| 8 | GE HealthCare Technologies | 28.08 Bn | 26.02 Bn | 1.98 Bn | -30.89% |
| 9 | Steris | 19.80 Bn | 19.37 Bn | 697.10 Mn | 51.01% |
| 10 | Lensar | 70.05 Mn | 70.34 Mn | 6.38 Mn | 167.24% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 167.24% |
| Dec 31, 2025 | 92.59% |
| Sep 30, 2025 | -138.46% |
| Jun 30, 2025 | 81.01% |
| Mar 31, 2025 | -1,121.05% |
| Dec 31, 2024 | -362.86% |
| Sep 30, 2024 | -200.00% |
| Jun 30, 2024 | 2.47% |
| Mar 31, 2024 | 52.50% |
| Dec 31, 2023 | -52.17% |
| Sep 30, 2023 | 133.33% |
| Jun 30, 2023 | -20.90% |
| Mar 31, 2023 | 40.30% |
| Dec 31, 2022 | 42.50% |
| Sep 30, 2022 | 40.00% |
| Jun 30, 2022 | -42.55% |
| Mar 31, 2022 | -19.64% |
| Dec 31, 2021 | -66.67% |
| Sep 30, 2021 | -1.56% |
| Jun 30, 2021 | 88.81% |